Iatrogenic Asthma Associated with Adrenergic Aerosols
Author:
- 1 November 1966
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 65 (5) , 985-995
Abstract
Because of their speed and effectiveness sympathomimetic aerosols have become established as one of the mainstays in the management of the reversible component of diffuse airway obstruction. Although the early clinical application of these aerosols is almost entirely based on short-term challenge experiments often conducted in normal subjects, there is now a tendency to study the response of asthmatic patients over more prolonged periods of time (1-4). The recognized side effects of sympathomimetic aerosols (5) are generally attributable to excessive systemic absorption, and sudden death may occur in the asthmatic when adrenergic drugs are used to excess (6-8). In addition,Keywords
This publication has 20 references indexed in Scilit:
- "Bronchodilator" action of deptropine citrate with and without isoprenaline by inhalation.BMJ, 1965
- DANGEROUS EFFECTS OF ISOPRENALINE IN MYOCARDIAL FAILUREThe Lancet, 1965
- COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASESThe American Journal of the Medical Sciences, 1965
- EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICSThe Lancet, 1964
- Variation of Drug Action on Airway Obstruction in ManThorax, 1964
- Some Adrenergic Drugs and Atropine Methonitrate Given by Inhalation for Asthma: A Comparative StudyBMJ, 1964
- The veterans administration-army cooperative study of pulmonary functionThe American Journal of Medicine, 1961
- Short Communication: A Slow Reacting Substance in Anaphylaxis—“SRS‐A”1956
- Lung function studiesThe American Journal of Medicine, 1951
- Clinical effects of epinephrine by inhalationJournal of Allergy, 1948